Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne S De Groot

Showing results (31-40 of 197) with videos related to

Pageof 20
Sort By:
Expert Review of Clinical Pharmacology|October 30, 2013
Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologicsAnne S De Groot, Frances Terry, Leslie Cousens, et al.
Expert Opinion on Drug Discovery|June 1, 2012
Harnessing the power of genomics and immunoinformatics to produce improved vaccinesLeonard Moise, Leslie Cousens, Joanna Fueyo, et al.
Medicine and Health, Rhode Island|December 15, 2011
Clínica Esperanza/Hope Clinic clinical outcomes review: February-July 2011Alexandra Bicki, Ralph Rogers, Vinnie Velasquez, et al.
Journal of Leukocyte Biology|June 5, 2013
Regulatory T cell epitopes (Tregitopes) in IgG induce tolerance in vivo and lack immunogenicity per seYan Su, Robert Rossi, Anne S De Groot, et al.
Human Immunology|December 3, 2014
Tregitope: Immunomodulation powerhouseLeslie Cousens, Nader Najafian, William D Martin, et al.
Human Vaccines & Immunotherapeutics|June 25, 2026
Reduced T cell epitope cross-conservation and immunogenic potential is associated with emergence of a dominant influenza subclade K in 2025Andres H Gutierrez, Jacob Tivin, Ben Gabriel, et al.
Journal of Biomedicine & Biotechnology|July 21, 2011
Emerging vaccine informaticsYongqun He, Rino Rappuoli, Anne S De Groot, et al.
Journal of Biomedicine & Biotechnology|July 21, 2011
Vaccine informaticsYongqun He, Rino Rappuoli, Anne S De Groot, et al.
Journal of Biomedicine & Biotechnology|August 14, 2010
A method for individualizing the prediction of immunogenicity of protein vaccines and biologic therapeutics: individualized T cell epitope measure (iTEM)Tobias Cohen, Leonard Moise, Matthew Ardito, et al.
Human Vaccines & Immunotherapeutics|July 10, 2015
8th vaccine renaissance: A creative nexus for vaccine developersHeather Johnson, Lenny Moise, Austin Menge, et al.
Pageof 20

Showing results (31-40 of 197) with videos related to

Sort By:
Pageof 20
Expert Review of Clinical Pharmacology|October 30, 2013
Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologicsAnne S De Groot, Frances Terry, Leslie Cousens, et al.
Expert Opinion on Drug Discovery|June 1, 2012
Harnessing the power of genomics and immunoinformatics to produce improved vaccinesLeonard Moise, Leslie Cousens, Joanna Fueyo, et al.
Medicine and Health, Rhode Island|December 15, 2011
Clínica Esperanza/Hope Clinic clinical outcomes review: February-July 2011Alexandra Bicki, Ralph Rogers, Vinnie Velasquez, et al.
Journal of Leukocyte Biology|June 5, 2013
Regulatory T cell epitopes (Tregitopes) in IgG induce tolerance in vivo and lack immunogenicity per seYan Su, Robert Rossi, Anne S De Groot, et al.
Human Immunology|December 3, 2014
Tregitope: Immunomodulation powerhouseLeslie Cousens, Nader Najafian, William D Martin, et al.
Human Vaccines & Immunotherapeutics|June 25, 2026
Reduced T cell epitope cross-conservation and immunogenic potential is associated with emergence of a dominant influenza subclade K in 2025Andres H Gutierrez, Jacob Tivin, Ben Gabriel, et al.
Journal of Biomedicine & Biotechnology|July 21, 2011
Emerging vaccine informaticsYongqun He, Rino Rappuoli, Anne S De Groot, et al.
Journal of Biomedicine & Biotechnology|July 21, 2011
Vaccine informaticsYongqun He, Rino Rappuoli, Anne S De Groot, et al.
Journal of Biomedicine & Biotechnology|August 14, 2010
A method for individualizing the prediction of immunogenicity of protein vaccines and biologic therapeutics: individualized T cell epitope measure (iTEM)Tobias Cohen, Leonard Moise, Matthew Ardito, et al.
Human Vaccines & Immunotherapeutics|July 10, 2015
8th vaccine renaissance: A creative nexus for vaccine developersHeather Johnson, Lenny Moise, Austin Menge, et al.
Pageof 20